Australia, March 25 -- Vectura Fertin Pharma Switzerland S.A, owns the trademark (2484971) for 'ASPEYA' till Sept. 24, 2034.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical products, nutraceuticals, vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions; pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum; medicated cannabinoids.], 10 [Medical devices; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers; dry powder inhalers (DPI); nebulizers; pressurized metered-dose inhalers (pMDI).], 42 [Medical research services; scientific research services; pharmaceutical development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.] and 44 [Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.]
Type of Mark: Word
Date of Acceptance: Sept. 27, 2024
Registration Advertised: March 24
For further details contact Ironside McDonald Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2484971.
Disclaimer: Curated by HT Syndication.
